Tai Andong 350 million yuan to buy Kang Love multi-Force medicine electric Business Field

Tai Andong (002433,SZ) has finally made substantial progress in his coveted power-quotient map. On the evening of September 17, Tai an Tang issued a notice that the company intends to buy 350 million Yuan Guangdong Kang Love chain Pharmacies Limited (hereinafter referred to more than Kang Love) 100% equity, which quickly cut into the field of pharmaceutical and electronic business.

Tai Andong in the bulletin pointed out that E-commerce has infiltrated all aspects of life, the company through the layout of medicine online business, speed up the line under the integration, improve product competitive advantage and customer consumption experience, this is the traditional consumer industry trends.

Priced 350 million yuan to buy Kang Love more

Compared to the self-built platform, Tai an Tang's electric dealer layout is "copied the path."

The bulletin shows that Kang Love was founded in July 2010, the company owns more than the Internet pharmacy (self-built platform), Kang-love-Large pharmacy flagship store (CAT) and mobile Internet web side, has formed a good brand effect. As of March 2014, Kang Love has been in the computer, mobile phones, mobile apps, micro-letters and other channels to provide more sophisticated purchase inquiries and trading services, while Kang love with the cat has established a long-term stable good relations of cooperation, with the help of the rapid development of the cat platform, 2012, 2013 1~ July sales in the day Cat online pharmacy ranked top three.

Kang Love more than last year to achieve business income of 160 million yuan, to achieve a net profit of 3.04 million yuan; this year from January to July, the realization of revenue of 180 million yuan, to achieve a net profit of 6.26 million yuan. Management shareholder Commitment Kang Love more than 2014, 2015, 2016 and 2017 to achieve sales income is not less than 280 million yuan, 640 million yuan, 1.15 billion yuan and 1.45 billion yuan; 2014, 2015, The net profit achieved in 2016 and 2017 is not less than 5 million yuan, 8 million yuan, 20 million yuan and 30 million yuan respectively.

Tai Andong said that the acquisition, on the one hand through the professional team of personnel docking, will be in the supply chain management capabilities, customer service capabilities, online promotion and service to enhance the ability to promote the help, and continuously optimize the user experience; On the other hand, Kang Love has accumulated a certain scale of online consumer groups, For the future of the company's business development and offline store benefits to bring impetus.

The potential of pharmaceutical electric business is huge

In fact, the loosening of the national policy level this year has brought unprecedented development opportunity to the pharmaceutical electric business, including Tai Andong, many listed companies have been looking for the right opportunity to enter the electric business field. Tai Andong announced in June this year, "Investor Relations activity record sheet" revealed that the company attaches great importance to the future of the construction of electric business platform, last year, the establishment of E-commerce department, exerting the company's pharmaceutical makeup and health products market. The following company intends to further expand the layout in the field of electrical business.

In September this year, Tai an church in preparation for nearly a year of non-public issues of shares finally landed, the total fund-raising 1.604 billion yuan. It said in the announcement that the non-public offering of the shares in place after the fund-raising, the company will be in accordance with the actual needs and priorities of the project will raise funds into the electricity and chain business, Bozhou Chinese herbal medicine characteristics of Industrial Park, Changbai Mountain Ginseng Industrial Park, Guangdong Hongxing Group Co., Ltd. new plant and Tai an hall outside the workshop, such as construction projects, The proposed investment amounts are 401.42 million yuan, 401.38 million yuan, 401.19 million yuan, 251.23 million yuan and 150.06 million yuan respectively.

In other words, Tai an Tang has put the electric and chain business in the current most important strategic position, the amount of investment accounted for 1/4 of the fund-raising. But for faster and better cut into the pharmaceutical business, the company intends to implement the project mainly in the form of acquisitions, and change the use of the Fund. Through the acquisition, Tai an Tang from a first entry into the industry to shake the ranks of tens of billions of dollars in the size of the drug dealers in the forefront of the camp.

According to the data obtained in the last three years, the market of the pharmaceutical electric business is infinitely good, and the growth rate is almost twice times every year. China's online Pharmacy council data show that China's pharmaceutical industry in the national scale from 2010 to 200 million Yuan, 2013 has reached 4.2 billion yuan. But compared with the United States and other developed countries, China's pharmaceutical electrical business volume is still small, there is a huge space for growth. At the same time, China has gradually entered the age of population aging, which will have a greater impact on China's social and economic aspects. Especially for the pharmaceutical industry, this will directly stimulate the rapid growth of China's pharmaceutical consumption. In the face of such a vast industry blue sea, the entrants hope to gain a foothold, while there are more outsiders waiting for opportunities to cut.

Wen/Chenfeng